J&J bids for EU OK on Legend CAR-T; FDA extends review period for Ardelyx's phosphorus control drug
J&J may be on its way to its first cell therapy approval on two continents.
The big pharma announced on Friday that they had …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
